Saturday, December 10, 2022
wellness India Expo
Home Tags Niti Aayog

Tag: Niti Aayog

BioVoice eMagazine December 2022 Issue 3 Volume 3

Click to Read: BioVoice News December 2022 Issue 3 Volume 3 The Cover Story in the current edition focuses on India's strong biotech R&D segment...

Atal Innovation Mission launches fresh applications for Community Innovator Fellowship

Community Innovator Fellow is an individual with an entrepreneurial mind-set, with an idea to solve a community challenge through her/his enterprise

Immense benefits of applying AI in agriculture: Experts

Indian startups need access to data and market to tackle technology adoption in agriculture: Anna Roy, Senior Adviser, NITI Aayog

AIM-PRIME Playbook to help academicians launch deep-tech spin-offs

Atal Innovation Mission’s AIM PRIME program sees cohort raising Rs 20 crore in funding

Innovations key to five trillion economy- Dr Jitendra Singh

Minister highlighted the role of Atal Innovation Mission programmes in supporting more than 2,200 startups in all the major fields of innovation like health-tech, fin-tech, agri-tech, AI-ML, IoT and other sectors of public importance.

Pfizer INDovation program to incubate & commercialize Indian healthcare startups launched

Customized incubation support across technology incubation centers like the IITs and other major technology institutes across India; grant upto Rs. 65 lakh per selected start-up

Two years into the pandemic: BioAsia 2022 announces a stellar speaker...

The panel discussion will feature pioneers, innovators and leaders, the likes of Dr. Soumya Swaminathan (Chief Scientist, World Health Organization); Dr. Peter Piot (Director, EU Chief Scientific Advisor Epidemics), and Mr. Amitabh Kant (CEO, NITI Aayog) among others

NITI Aayog & USAID collaborate to accelerate health innovation & entrepreneurship...

Atal Innovation Mission and SAMRIDH Healthcare blended finance facility announce joint partnership and issue a call for proposals

Mapmygenome expands to North India, begins operations in Delhi-NCR

The strategic move to start operations in Delhi-NCR aims to close the gap by fulfilling an existing need for genomic testing, genetic counseling services and other preventive health tests in North India

Pharma industry reiterates its commitment to US$ 130 billon by 2030

Innovation, R&D, partnership & policy support to be key growth drivers as echoed at Global Innovation Summit-2021 organized by Indian Pharmaceutical Alliance